Opioid addiction implant maker Braeburn Pharma pulls IPO

(Reuters) - Braeburn Pharmaceuticals Inc, the maker of the first long-acting implant to treat opioid addiction in the United States, said on Thursday that it had decided not to proceed with its...

from Reuters: Deals http://ift.tt/2l0pRqo
via IFTTT